Literature DB >> 35129734

Laparoscopic transverse colectomy with extended complete mesocolic excision for mid-transverse colon cancer.

G N Piozzi1, S M Rusli1,2, J M Choo1, J S Kim1, S H Kim3.   

Abstract

Entities:  

Keywords:  Colon cancer; Complete mesocolic excision; Infrapyloric lymph nodes; Laparoscopy; Transverse colectomy; Transverse colon

Mesh：

Year:  2022        PMID： 35129734     DOI： 10.1007/s10151-021-02567-9

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.699


× No keyword cloud information.
  4 in total

1.  Operative Method for Transverse Colon Carcinoma: Transverse Colectomy Versus Extended Colectomy.

Authors:  Choon Seng Chong; Jung Wook Huh; Bo Young Oh; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Woo Yong Lee
Journal:  Dis Colon Rectum       Date:  2016-07       Impact factor: 4.585

2.  A Transverse Colectomy is as Safe as an Extended Right or Left Colectomy for Mid-Transverse Colon Cancer.

Authors:  Lieve G J Leijssen; Anne M Dinaux; Ramzi Amri; Hiroko Kunitake; Liliana G Bordeianou; David L Berger
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

3.  Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.

Authors:  Charlie M Wray; Argyrios Ziogas; Marcelo W Hinojosa; Hoa Le; Michael J Stamos; Jason A Zell
Journal:  Dis Colon Rectum       Date:  2009-08       Impact factor: 4.585

4.  Venous anatomy of the right colon: precise structure of the major veins and gastrocolic trunk in 58 cadavers.

Authors:  Shigeki Yamaguchi; Hiroya Kuroyanagi; Jeffrey W Milsom; Richard Sim; Hiroshi Shimada
Journal:  Dis Colon Rectum       Date:  2002-10       Impact factor: 4.585
  4 in total
  1 in total

1.  Laparoscopic transverse colectomy with complete mobilization of right-sided mesocolon and ileocecum preservation for mid-transverse colon cancer.

Authors:  Liang Yu; Zhifen Chen; Huimin Lin; Pan Chi
Journal:  Tech Coloproctol       Date:  2022-09-02       Impact factor: 3.699
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.